Kenvue Inc. $KVUE Shares Sold by Strs Ohio

Strs Ohio cut its holdings in Kenvue Inc. (NYSE:KVUE) by 55.4% during the third quarter, Holdings Channel reports. The institutional investor owned 524,539 shares of the company’s stock after selling 651,535 shares during the quarter. Strs Ohio’s holdings in Kenvue were worth $8,513,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the business. NBT Bank N A NY boosted its position in shares of Kenvue by 180.3% during the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after purchasing an additional 1,006 shares in the last quarter. Salomon & Ludwin LLC purchased a new stake in Kenvue during the third quarter worth about $25,000. Trust Co. of Vermont grew its position in Kenvue by 266.8% during the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after buying an additional 1,150 shares during the period. New England Capital Financial Advisors LLC increased its holdings in Kenvue by 81.4% in the third quarter. New England Capital Financial Advisors LLC now owns 2,563 shares of the company’s stock valued at $42,000 after buying an additional 1,150 shares in the last quarter. Finally, First Pacific Financial purchased a new stake in shares of Kenvue during the 2nd quarter worth approximately $54,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Activity at Kenvue

In other news, Director Jeffrey C. Smith bought 3,200,000 shares of Kenvue stock in a transaction dated Friday, December 12th. The shares were acquired at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the transaction, the director owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.17% of the company’s stock.

Kenvue Trading Up 0.4%

NYSE:KVUE opened at $17.82 on Monday. The business’s 50-day moving average is $17.05 and its two-hundred day moving average is $18.13. The firm has a market capitalization of $34.14 billion, a PE ratio of 23.76 and a beta of 0.60. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69.

Kenvue (NYSE:KVUE) last issued its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.01. The company had revenue of $3.76 billion during the quarter, compared to the consensus estimate of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The company’s revenue was down 3.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were paid a dividend of $0.2075 per share. The ex-dividend date was Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.7%. Kenvue’s dividend payout ratio (DPR) is currently 110.67%.

Wall Street Analyst Weigh In

Several research firms have weighed in on KVUE. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Deutsche Bank Aktiengesellschaft set a $18.00 price objective on Kenvue in a report on Friday, October 24th. Barclays lifted their target price on Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Jefferies Financial Group reduced their price objective on Kenvue from $25.00 to $23.00 and set a “buy” rating on the stock in a research note on Monday, October 27th. Finally, Evercore ISI set a $18.00 target price on Kenvue in a report on Tuesday, October 28th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and twelve have issued a Hold rating to the stock. According to MarketBeat, Kenvue has an average rating of “Hold” and an average price target of $20.23.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.